Robert Hernandez
Internal Medicine · Sherman, TXNPI 1104998046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 29.6% of the total. Reporting peaked in 2019 at $1,142 and has fallen 96.2% since, to $43 in 2023.
Across 157 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$757
- Lilly USA, LLC$318
- Jazz Pharmaceuticals Inc.$271
- Pfizer$143
- Clarus Therapeutics Inc.$134
- Genentech USA, Inc.$109
- plus $830 from 19 others
What the payments were for
- Food & beverage$2,51898%
- Other$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $757 |
| Lilly USA, LLC | 18 | $318 |
| Jazz Pharmaceuticals Inc. | 11 | $271 |
| Pfizer | 15 | $143 |
| Clarus Therapeutics Inc. | 9 | $134 |
| Genentech USA, Inc. | 1 | $109 |
| Indivior Inc. | 8 | $108 |
| Merck | 6 | $89 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Antares Pharma, Inc. | 4 | $80 |
| AstraZeneca | 5 | $64 |
| Optos, Inc. | 2 | $60 |
| Acadia Pharmaceuticals Inc | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Shire North American Group Inc | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 2 | $41 |
| Orexo US, Inc. | 2 | $28 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,561 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Sherman
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.